J Korean Med Sci.
2014 Mar;29(3):460-460. 10.3346/jkms.2014.29.3.460.
Erratum: Correction of Notes. Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy
- Affiliations
-
- 1Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- KMID: 1734939
- DOI: http://doi.org/10.3346/jkms.2014.29.3.460
Abstract
- We found an error in our published article.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy
- Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection
- Interstitial pneumonitis associated with infliximab therapy in a rheumatoid arthritis patient
- Measurement of Inflammatory Cytokines in Patients with Rheumatoid Arthritis
- A Case of Tumor Necrosis Factor-alpha Inhibitors-induced Pustular Psoriasis
